Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures
NCT: NCT07632638 · RECRUITING
Brief Summary
CONSTELAR is a prospective, single-arm, multi-specialty registry designed to evaluate the safety and intraoperative performance of the RonovoTM robotic surgical platform in adult patients undergoing elective oncological surgery. The study enrolls patients across four surgical specialties (Digestive Surgery, Thoracic Surgery, Urology, and Gynecology) at a single academic center. Primary endpoints include 30-day and 90-day complication rates (Clavien-Dindo classification), operative times, conversion rates, estimated blood loss, and device-related technical failures. Secondary endpoints encompass length of hospital stay, Intensive Care Unit (ICU) admission, readmission/reoperation rates, and oncological surgical outcomes (resection margins, lymph node harvest). The study aims to provide initial safety and feasibility data to support the regulatory pathway for the RonovoTM platform in Latin America.
Frequently Asked Questions
What is Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures?
Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures is a clinical trial registered under NCT07632638. Current status: RECRUITING.
What is the status of NCT07632638?
The current status of NCT07632638 (Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures) is: RECRUITING.
When did Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures start?
Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures started on 2026-06-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.